Desonide sodium phosphate

DB15835InvestigationalSmall molecule

Desonide sodium phosphate is a medication indicated in the treatment of external eye inflammation.

Chemical structure of Desonide sodium phosphate
Formula / weight
C24H31Na2O9P · 540.456 g/mol (avg)

Resolves to

Compound
UNII36H4OGY275CAS94087-98-6
Structure
InChIKeyIHTZFPUWMRSEMG-PXQDNWDYSA-LSMILES[Na+].[Na+].[H][C@@]12C[C@@]3([H])[C@]4([H])CCC5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COP([O-])([O-])=O

What you can answer from here — as of April 02, 2025

16ContraindicationsEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Desonide sodium phosphate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In